EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is Novavax (NVAX) A Potential Opportunity After Recent Share Price Weakness
Assessing Novavax (NVAX) Valuation After Recent Share Price Swings And Royalty Deal Outlook
Traders Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX)
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Will Novavax's New R&D Chief Reframe Its Partnership-Led Strategy and Long-Term Story (NVAX)? - Simply Wall St News
Novavax (NASDAQ:NVAX) Shares Down 5.4% - Should You Sell? - Daily Political
Novavax (NASDAQ:NVAX) Shares Pass Above Two Hundred Day Moving Average - Should You Sell? - Stock Observer
2 Growth Stocks Set to Flourishand 1 We Question
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average - Here's Why
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - Daily Political
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
A Look Back at Biotechnology Stocks' Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
Evaluating Novavax (NVAX) Valuation As Licensing Deal And Recent Returns Shape Market Expectations
3 Stocks Under $50 That Concern Us
Novavax, Inc. (NASDAQ:NVAX) Receives $11.88 Average Target Price from Analysts - Markets Daily
Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks
Q3 Earnings Forecast for Novavax Issued By Zacks Research
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Q3 Earnings Estimate for Novavax Issued By Zacks Research
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations
6 years since lockdown, here's a look at COVID vaccine guidance today - Yahoo News Canada
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
Assessing Novavax (NVAX) Valuation After Recent Share Price Volatility And Vaccine Partnership Momentum
3 Profitable Stocks That Concern Us
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Brokerages
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
Novavax (NASDAQ:NVAX) Trading 7.6% Higher - Should You Buy?
Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Assessing Novavax (NVAX) Valuation After Strong 2025 Results And Return To Profitability
Novavax (NASDAQ:NVAX) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
Novavax News
Super Micro Computer Inc (NASDAQ: SMCI) stock outlook: SMCI shares rise 2.8%, what’s next?
Siren (SIREN) Price Analysis: SIREN Crypto Short-Term Outlook and Risks
UAE Financial Market Analysis 2026: Banking Profits, Crypto & Blockchain, Digital Finance Revolution
High potential ai stocks: Arm Holdings (ARM) stock, ASML stock, ASMI stock
Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook
Latest news
Show more
Gold Price Today, April 8: XAU/USD Surges Toward $4,900 as US-Iran Agree to Two-Week Ceasefire
Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?
Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data
US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases
SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation
